These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6624652)

  • 1. Plasma level monitoring of antiarrhythmic drugs.
    Kates RE
    Am J Cardiol; 1983 Sep; 52(6):8C-13C. PubMed ID: 6624652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic monitoring of antiarrhythmic drugs.
    Kates RE
    Ther Drug Monit; 1980; 2(2):119-26. PubMed ID: 6762707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of plasma concentration monitoring in the evaluation of response to antiarrhythmic drugs.
    Woosley RL
    Am J Cardiol; 1988 Oct; 62(12):9H-17H. PubMed ID: 3052009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolites of cardiac antiarrhythmic drugs: their clinical role.
    Kates RE
    Ann N Y Acad Sci; 1984; 432():75-89. PubMed ID: 6441496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of antiarrhythmic drug plasma concentration monitoring.
    Follath F; Ganzinger U; Schuetz E
    Clin Pharmacokinet; 1983; 8(1):63-82. PubMed ID: 6404580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response optimization of drug dosage: antiarrhythmic studies with tocainide.
    Meffin PJ; Winkle RA; Blaschke TF; Fitzgerald J; Harrison DC; Harapat SR; Bell PA
    Clin Pharmacol Ther; 1977 Jul; 22(1):42-57. PubMed ID: 872495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring of antiarrhythmic drugs.
    Jürgens G; Graudal NA; Kampmann JP
    Clin Pharmacokinet; 2003; 42(7):647-63. PubMed ID: 12844326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The myocardial levels of the antiarrhythmic drugs: clinical relevance.
    Ferrari M; Padrini R; Piovan D; Bova S; Moretto R; Cargnelli G
    G Ital Cardiol; 1986 Aug; 16(8):660-2. PubMed ID: 3792731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM; Kates RE
    Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of plasma concentrations of antiarrhythmic drugs.
    Edvardsson N; Olsson SB
    Eur Heart J; 1987 Mar; 8 Suppl A():83-9. PubMed ID: 3556180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of pharmacokinetics for antiarrhythmic drugs.
    Harrison DC
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():65-72. PubMed ID: 6803703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics and plasma concentrations of anti-arrhythmic drugs].
    Jaillon P
    Ann Cardiol Angeiol (Paris); 1984 Dec; 33(8):525-30. PubMed ID: 6529130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine-effective plasma concentrations of antiarrhythmic drugs on the two-stage coronary ligation arrhythmia.
    Hashimoto K; Satoh H; Shibuya T; Imai S
    J Pharmacol Exp Ther; 1982 Dec; 223(3):801-10. PubMed ID: 7143241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of blood level and metabolites to the antiarrhythmic effectiveness of encainide.
    Harrison DC; Kates RE; Quart BD
    Am J Cardiol; 1986 Aug; 58(5):66C-73C. PubMed ID: 3092622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of antiarrhythmic drugs for the clinician--medical emergencies and chronic treatment.
    Storstein L
    Eur Heart J; 1984 Sep; 5 Suppl B():59-62. PubMed ID: 6499872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma levels of anti-arrhythmic drugs and clinical effectiveness in the treatment of ventricular arrhythmias].
    Bracchetti D; Naccarella F; Guaragna RF; Palmieri M; Bartoletti A; Barbato G; Malini PL; Marchesini B; Ambrosioni E
    G Ital Cardiol; 1986 Aug; 16(8):648-59. PubMed ID: 3539687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of midazolam on pharmacokinetic parameters of procainamide in rabbits.
    Orszulak-Michalak D; Owczarek J; Wiktorowska-Owczarek AK
    Pol J Pharmacol; 2002; 54(2):151-5. PubMed ID: 12139112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Side effects of anti-arrhythmia drugs].
    Neugebauer A
    Z Gesamte Inn Med; 1984 Jun; 39(11):249-52. PubMed ID: 6475169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of plasma concentrations of anti-arrhythmia agents].
    Flouvat B
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():47-55. PubMed ID: 6803701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.
    Mitani GM; Steinberg I; Lien EJ; Harrison EC; Elkayam U
    Clin Pharmacokinet; 1987 Apr; 12(4):253-91. PubMed ID: 3297463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.